DASSAULT SYSTEMES SA ADR - DASTY STOCK NEWS

Dassault Systèmes SE has disclosed its trading activities for the period from September 24 to September 29, 2021, following the repurchase program approved by shareholders on May 26, 2021. During this time, a total of 1,400,384 shares were repurchased, with daily volumes ranging from 15,890 to 331,346 shares. The average acquisition prices varied each day, with the lowest being approximately 45.91 and the highest at 49.50 per share. Full details about the transactions can be found on their investor relations website.

AllStripes has appointed Sherwin Chen as Chief Legal Officer and Joe Walsh as Vice President, Head of Commercial. These appointments are aimed at supporting the company's growth in rare disease research. Chen brings nearly 20 years of legal expertise from roles at Color Health and Roche, while Walsh has significant experience from Komodo Health. Both leaders will enhance AllStripes' efforts to empower the rare disease community and expand partnerships within the life sciences sector.

Dassault Systèmes disclosed the trading activities for its own shares from September 16 to September 22, 2021, as part of the repurchase program approved by shareholders on May 26, 2021. During this period, the company reported numerous transactions across various markets, including XPAR and DXE. The total volume of shares traded varied daily with acquisition prices averaging approximately €49.49. Detailed information on these transactions is available on the company's investor relations website.

Dassault Systèmes disclosed its share repurchase activities conducted between September 8 and September 15, 2021. The report details daily trading transactions, including the number of shares bought and the average acquisition prices. Noteworthy transactions included the purchase of 242,385 shares at an average price of €49.3991 on September 15, 2021. Investors can find a comprehensive breakdown of these trades on the company's investor relations website.

Nextech AR Solutions Corp (OTCQB: NEXCF) has launched its innovative CAD to POLY solution, aimed at transforming CAD files into optimized 3D meshes for AR applications. This advancement positions Nextech to capitalize on the $11 billion CAD market. A provisional patent has been filed, enhancing scalability for their ecommerce 3D models. The company plans to offer this CAD to POLY technology as a SaaS product in 2022, which is already in use by select customers. Key players in the CAD market, including Dassault Systemes and Autodesk, have been identified as potential clients.

BIOMEDevice Boston is set to return on September 21-22 at the Boston Convention & Exhibition Center, bringing together the biomedical industry. The event will feature the Startup Stadium, in partnership with the Massachusetts Medical Device Industry Council (MassMEDIC), showcasing emerging medical technology companies. Attendees can expect a full day of educational content, including insights into the medtech investment landscape. With over $100 million in VC funding noted in the life sciences sector, the event highlights the increasing importance of education in navigating this robust investment.

Dassault Systèmes, as of August 31, 2021, reported a total of 1,331,000,349 outstanding shares and 1,991,474,694 voting rights. This figure includes voting rights from all outstanding shares, even those with suspended rights, as outlined under the Autorité des marchés financiers regulations. Shareholders are advised to consult Article 223-11 regarding ownership threshold declarations. For any threshold crossing declarations, investors should contact the company’s Investor Relations Service.

Dassault Systèmes announced the deployment of its DELMIA Quintiq applications at BMW Group production sites in Dingolfing, Leipzig, and Regensburg for E-Drive components.

The program aims to enhance manufacturing efficiency and decision-making amid evolving automotive supply chains. By synchronizing demand and lowering costs, the application is designed to optimize productivity and inventory levels. This deployment represents a significant step in BMW's digital transformation strategy to meet rising demand for electric vehicles.

AllStripes has successfully completed a $50 million Series B funding round, led by Lux Capital and supported by JAZZ Venture Partners and others. This financing aims to launch 100 new rare disease research programs and enhance the company's technology and operational capabilities. Currently partnering with over 30 advocacy organizations, AllStripes strives to improve research insights and empower patient engagement in rare diseases. The investment aims to increase treatment options for patients, addressing the 7,000 rare diseases with only 5% having available treatments.